| 1 |
刘大为. 重症医学: 学科体系的形成与发展 [J]. 中华危重病急救医学, 2022, 34(1): 1-4.
|
| 2 |
张丽娜, 蒋渊, 艾宇航. 重症神经系统疾病患者救治: 保护为先 [J/OL]. 中华重症医学电子杂志, 2020, 6(3): 241-243.
|
| 3 |
Routsi C, Stamataki E, Nanas S, et al. Increased levels of serum S100B protein in critically ill patients without brain injury [J]. Shock, 2006, 26(1): 20-24.
|
| 4 |
Piazza O, Russo E, Cotena S, et al. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis [J]. Br J Anaesth, 2007, 99(4): 518-521.
|
| 5 |
Marshak DR, Watterson DM, Van Eldik LJ. Calcium-dependent interaction of S100B, troponin C, and calmodulin with an immobilized phenothiazine [J]. Proc Natl Acad Sci U S A, 1981, 78(11): 6793-6797.
|
| 6 |
Michetti F, D'Ambrosi N, Toesca A, et al. The S100B story: from biomarker to active factor in neural injury [J]. J Neurochem, 2019, 148(2): 168-187.
|
| 7 |
Balança B, Desmurs L, Grelier J, et al. DAMPs and RAGE pathophysiology at the acute phase of brain injury: an overview [J]. Int J Mol Sci, 2021, 22(5).
|
| 8 |
Donato R, Sorci G, Riuzzi F, et al. S100B's double life: intracellular regulator and extracellular signal [J]. Biochim Biophys Acta, 2009, 1793(6): 1008-1022.
|
| 9 |
Stocchetti N, Carbonara M, Citerio G, et al. Severe traumatic brain injury: targeted management in the intensive care unit [J]. Lancet Neurol, 2017, 16(6): 452-464.
|
| 10 |
丁燕晶, 叶嘉辉, 莫海军, 等. 重型颅脑损伤患者血清高迁移率族蛋白B1、白细胞介素-1和白细胞介素-6、S100B蛋白 的水平变化及临床意义 [J]. 中国药物经济学, 2018, 13(5): 34-37.
|
| 11 |
尹文国, 翁山山, 赖仕宇, 等. 联合GCS评分、CT评分与血清S100B蛋白可评估急性颅脑创伤患者损伤程度及早期预后 [J]. 南方医科大学学报, 2021, 41(4): 543-548.
|
| 12 |
张志强. 血清S100B检测对创伤性脑损伤的诊断价值 [J]. 国际检验医学杂志, 2021, 42(4): 457-460, 464.
|
| 13 |
顾志伟, 屠传建, 宋大刚, 等. 血清NSE、S100B蛋白和颅脑损伤程度及预后的相关性研究 [J]. 浙江创伤外科, 2019, 24(3): 524-526.
|
| 14 |
Janigro D, Kawata K, Silverman E, et al. Is salivary S100B a biomarker of traumatic brain injury? [J]. A Pilot Study. Front Neurol, 2020, 11: 528.
|
| 15 |
Kabadi SV, Stoica BA, Zimmer DB, et al. S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury [J]. J Cereb Blood Flow Metab, 2015, 35(12): 2010-2020.
|
| 16 |
杜若桑, 苑鸿雯, 郑淑美, 等. 早期针刺对创伤性脑损伤大鼠血清GFAP和S-100B蛋白水平的影响 [J]. 中国中医急症, 2017, 26(9): 1589-1592.
|
| 17 |
Gu Z, Li L, Li Q, et al. Polydatin alleviates severe traumatic brain injury induced acute lung injury by inhibiting S100B mediated NETs formation [J]. Int Immunopharmacol, 2021, 98: 107699.
|
| 18 |
《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2019》概要 [J]. 中国脑血管病杂志, 2020, 17(5): 272-281.
|
| 19 |
Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B [J]. Cerebrovasc Dis, 2009, 27(3): 295-302.
|
| 20 |
Moritz S, Warnat J, Bele S, et al. The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage [J]. J Neurosurg Anesthesiol, 2010, 22(1): 21-31.
|
| 21 |
James ML, Blessing R, Phillips-Bute BG, et al. S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage [J]. Biomarkers, 2009, 14(6): 388-394.
|
| 22 |
Beer C, Blacker D, Bynevelt M, et al. Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke [J]. J Neuroinflammation, 2010, 7: 71.
|
| 23 |
Aineskog H, Johansson C, Nilsson R, et al. Serum S100B correlates with health-related quality of life and functional outcome in patients at 1 year after aneurysmal subarachnoid haemorrhage [J]. Acta Neurochir (Wien), 2022,164(8): 2209-2218.
|
| 24 |
González-García S, González-Quevedo A, Fernández-Concepción O, et al. Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients [J]. Clin Biochem, 2012, 45(16-17): 1302-1307.
|
| 25 |
Chong ZZ. S100B raises the alert in subarachnoid hemorrhage [J]. Rev Neurosci, 2016, 27(7): 745-759.
|
| 26 |
Zhou S, Zhu W, Zhang Y, et al. S100B promotes microglia M1 polarization and migration to aggravate cerebral ischemia [J]. Inflamm Res, 2018, 67(11-12): 937-949.
|
| 27 |
Zhang JH, Li JK, Ma LL, et al. RNA interference-mediated silencing of S100B improves nerve function recovery and inhibits hippocampal cell apoptosis in rat models of ischemic stroke [J]. J Cell Biochem, 2018, 119(10): 8095-8111.
|
| 28 |
Cordeiro JL, Neves JD, Vizuete AF, et al. Arundic Acid (ONO-2506), an inhibitor of S100B protein synthesis, prevents neurological deficits and brain tissue damage following intracerebral hemorrhage in male wistar rats [J]. Neuroscience, 2020, 440: 97-112.
|
| 29 |
Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis [J]. Lancet Neurol, 2014, 13(6): 630-636.
|
| 30 |
Wu L, Feng Q, Ai ML, et al. The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy [J]. Sci Rep, 2020, 10(1): 7718.
|
| 31 |
Yao B, Zhang LN, Ai YH, et al. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res, 2014, 39(7): 1263-1269.
|
| 32 |
Erikson K, Ala-Kokko TI, Koskenkari J, et al. Elevated serum S-100 beta in patients with septic shock is associated with delirium [J]. Acta Anaesth Scand, 2019, 63(1): 69-73.
|
| 33 |
Calsavara AJ, Costa PA, Nobre V, et al. Prevalence and risk factors for post-traumatic stress, anxiety, and depression in sepsis survivors after ICU discharge [J]. Braz J Psychiatry, 2021, 43(3): 269-276.
|
| 34 |
胡丹, 齐共健, 刘开勋, 等. GFAP、MBP、S100β蛋白在脓毒症相关性脑病早期识别及病情评估中的临床应用价值 [J]. 徐州医科大学学报, 2020, 40(9): 691-694.
|
| 35 |
Lipcsey M, Olovsson M, Larsson E, et al. The brain is a source of S100B increase during endotoxemia in the pig [J]. Anesth Analg, 2010, 110(1): 174-180.
|
| 36 |
Rocha M, Vieira A, Michels M, et al. Effects of S100B neutralization on the long-term cognitive impairment and neuroinflammatory response in an animal model of sepsis [J]. Neurochem Int, 2021, 142: 104906.
|
| 37 |
Zhang L, Jiang Y, Deng S, et al. S100B/RAGE/Ceramide signaling pathway is involved in sepsis-associated encephalopathy [J]. Life Sci, 2021, 277: 119490.
|
| 38 |
Deng S, Ai Y, Gong H, et al. Mitochondrial dynamics and protective effects of a mitochondrial division inhibitor, Mdivi-1, in lipopolysaccharide-induced brain damage [J]. Biochem Biophys Res Commun, 2018, 496(3): 865-871.
|
| 39 |
Liu L, Zheng CX, Peng SF, et al. Evaluation of urinary S100B protein level and lactate/creatinine ratio for early diagnosis and prognostic prediction of neonatal hypoxic-ischemic encephalopathy [J]. Neonatology, 2010, 97(1): 41-44.
|
| 40 |
Zaigham M, Lundberg F, Olofsson P. Protein S100B in umbilical cord blood as a potential biomarker of hypoxic-ischemic encephalopathy in asphyxiated newborns [J]. Early Hum Dev, 2017, 112: 48-53.
|
| 41 |
Stammet P, Dankiewicz J, Nielsen N, et al. Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 ℃ and 36 ℃ [J]. Crit Care, 2017, 21(1): 153.
|
| 42 |
van Munster BC, Korevaar JC, Korse CM, et al. Serum S100B in elderly patients with and without delirium [J]. Int J Geriatr Psychiatry, 2010, 25(3): 234-239.
|
| 43 |
Nguyen DN, Huyghens L, Wellens F, et al. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO) [J]. Neurocrit Care, 2014, 20(3): 367-374.
|
| 44 |
Liu B, Xie Z, Liu G, et al. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-D-aspartate receptor encephalitis [J]. Clin Chim Acta, 2018, 480: 79-83.
|
| 45 |
Studahl M, Günther G, Rosengren L. Serum S-100B protein levels in patients with herpes simplex encephalitis and tick-borne encephalitis--a marker of CNS damage during the initial stage of disease [J]. J Neurol, 2009, 256(4): 586-590.
|
| 46 |
Aceti A, Margarucci LM, Scaramucci E, et al. Serum S100B protein as a marker of severity in Covid-19 patients [J]. Sci Rep, 2020, 10(1): 18665.
|
| 47 |
Renner NA, Redmann RK, Moroney-Rasmussen T, et al. S100β as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS [J]. Neuropathol Appl Neurobiol, 2012, 38(2): 162-174.
|
| 48 |
Rezaei O, Pakdaman H, Gharehgozli K, et al. S100 B: a new concept in neurocritical care [J]. Iran J Neurol, 2017, 16(2): 83-89.
|
| 49 |
Vedin T, Karlsson M, Edelhamre M, et al. Features of urine S100B and its ability to rule out intracranial hemorrhage in patients with head trauma: a prospective trial [J]. Eur J Trauma Emerg Surg, 2021, 47(5): 1467-1475.
|
| 50 |
Vizuete AFK, de Lima Cordeiro J, Neves JD, et al. Arundic acid (ONO-2526) inhibits stimulated-S100B secretion in inflammatory conditions [J]. Neurosci Lett, 2021, 751: 135776.
|
| 51 |
Ohtani R, Tomimoto H, Wakita H, et al. Expression of S100 protein and protective effect of arundic acid on the rat brain in chronic cerebral hypoperfusion [J]. Brain Res, 2007, 1135(1): 195-200.
|
| 52 |
Higashino H, Niwa A, Satou T, et al. Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid-(ONO-2506) treated stroke-prone spontaneously hypertensive rats [J]. J Neural Transm (Vienna), 2009, 116(10): 1209-1219.
|
| 53 |
Li Y, Yu ZX, Ji MS, et al. A pilot study of the use of Dexmedetomidine for the control of delirium by reducing the serum concentrations of brain-derived neurotrophic factor, neuron-specific enolase, and S100B in polytrauma patients [J]. J Intensive Care Med, 2019, 34(8): 674-681.
|